Live
- NASA Tracks Five Giant Asteroids on Close Approach to Earth Today
- Pushpa 2 Hits ₹1000 Crore in 6 Days: How It Compares to Other Top Indian Films
- Vivo X200 and X200 Pro Launched in India: Price, Specifications, and Features
- Nitin Gadkari Admits Feeling Embarrassed at Global Summits Over Rising Road Accidents in India
- Comprehensive Review on Indiramma Housing Survey and Welfare Initiatives Conducted via Video Conference
- Jogulamba Temple Records Rs 1.06 Crore Hundi Revenue in 150 Days
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
Nod for Sputnik vaccine soon: Dr Reddy's
Nod for Sputnik vaccine soon: Dr Reddy’s
Hyd’s pharma major partnered with Russia’s RDIF to bring vax to India
Hyderabad: Pharma major Dr Reddy's Laboratories expects the Russian-made Covid-19 vaccine, Sputnik V, to get approval from the Indian regulator in the next few weeks. "We expect to get the approval in the next few weeks.
It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42.
So, it is a two-dose vaccine and we expect it to be available in the next few weeks," according to Deepak Sapra, the company's CEO, APIs and Services.
Sapra, who was speaking in a webinar on Tuesday, was asked as to how soon Sputnik would be available and whether it is a one-dose or two doses vaccine.
Observing that trials of the vaccine have been conducted in Russia, India, the UAE and others, he said the Covid-19 vaccine demonstrated an efficacy of 91.6% according to the journal Lancet.
The data on trials is currently with the Indian regulator and the firm expects it to get approved in the next few weeks, he added.
"Now, what we have done in India, in addition to all this, we also conducted trials in India and evaluated the vaccine on the Indian population for both safety as well as for immunogenicity.
This data is currently with the Indian regulator and we expect it to get approved in the next few weeks," he said. Dr Reddy's has partnered with the Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India and other nations.
The webinar on "India's vaccination journey and the second wave of Covid-19' was conducted by the All India Professional Congress (AIPC), Telangana.
